ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

摘要:

The glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonists claimed the spotlight at the 69th Scientific Sessions of the American Heart Association [New Orleans, US; November 1996]. The ability of clopidogrel to reduce clinical events in patients with myocardial infarction (MI), ischaemic stroke or peripheral arterial disease (PAD) was studied in a head-to-head comparison with aspirin. Clopidogrel came out on top, although its benefits over aspirin were not as great as anticipated by the Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) trial researchers. In another study, the feasibility of using GPIIb/IIIa receptor antagonists in place of thrombolytic therapy to induce coronary flow after MI was investigated. The preliminary results with abciximab were encouraging.

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

摘要:

Four strategies are under investigation as possible ways of developing more immunogenic vaccines for protection againstMycobacterium tuberculosisinfection. These vaccines are greatly needed as the incidence of tuberculosis remains at a high level in both developed and developing countries. Some of the new approaches involved in tuberculosis vaccine development were discussed at the 3rd European Conference on Vaccinology [Berlin, Germany; October 1996].

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS

ISSN:1173-8324    

出版商:ADIS    

年代:1996

数据来源: ADIS